Repro-Med Systems Earnings Perspective: Return On Capital Employed

Comments
Loading...

According to Benzinga Pro data Repro-Med Systems KRMD posted a 18.74% decrease in earnings from Q2. Sales, however, increased by 18.53% over the previous quarter to $7.76 million. Despite the increase in sales this quarter, the decrease in earnings may suggest Repro-Med Systems is not utilizing their capital as effectively as possible. Repro-Med Systems reached earnings of $475 thousand and sales of $6.55 million in Q2.

Why Is ROCE Significant?

Return on Capital Employed is a measure of yearly pre-tax profit relative to capital employed by a business. Changes in earnings and sales indicate shifts in a company's ROCE. A higher ROCE is generally representative of successful growth of a company and is a sign of higher earnings per share in the future. A low or negative ROCE suggests the opposite. In Q3, Repro-Med Systems posted an ROCE of 0.04%.

Keep in mind, while ROCE is a good measure of a company's recent performance, it is not a highly reliable predictor of a company's earnings or sales in the near future.

ROCE is a powerful metric for comparing the effectiveness of capital allocation for similar companies. A relatively high ROCE shows Repro-Med Systems is potentially operating at a higher level of efficiency than other companies in its industry. If the company is generating high profits with its current level of capital, some of that money can be reinvested in more capital which will generally lead to higher returns and, ultimately, earnings per share (EPS) growth.

For Repro-Med Systems, the positive return on capital employed ratio of 0.04% suggests that management is allocating their capital effectively. Effective capital allocation is a positive indicator that a company will achieve more durable success and favorable long-term returns.

Analyst Predictions

Repro-Med Systems reported Q3 earnings per share at $-0.03/share, which beat analyst predictions of $-0.05/share.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!